Old Web
English
Sign In
Acemap
>
authorDetail
>
William Blum
William Blum
University of Chicago
Myeloid leukemia
Medicine
Cancer research
Oblimersen
Bone marrow
3
Papers
128
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dose-dependent activity of decitabine in Kasumi-1 cells
2011
Zhongfa Liu
Shujun Liu
Zhiliang Xie
William Blum
Danilo Perrotti
Peter Paschka
Rebecca B. Klisovic
John C. Byrd
Kenneth K. Chan
Guido Marcucci
Show All
Source
Cite
Save
Citations (0)
IN REPLY: The unacceptable toxicities seen in all four chronic lymphocytic leukemia (CLL) patients treated with lenalidomide at a
2008
Leslie A. Andritsos
Thomas S. Lin
William Blum
Cheryl Kefauver
Amy J. Johnson
John C. Byrd
Show All
Source
Cite
Save
Citations (0)
Phase I Study of Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients With Acute Myeloid Leukemia: Pharmacokinetics, Pharmacodynamics, and Clinical Activity
2005
Journal of Clinical Oncology
Guido Marcucci
Wendy Stock
Guowei Dai
Rebecca B. Klisovic
Shujun Liu
Marko I. Klisovic
William Blum
Cheryl Kefauver
Dorie Sher
Margaret Green
Mollie E. Moran
Kati Maharry
Steven Novick
Clara D. Bloomfield
James A. Zwiebel
Richard A. Larson
Michael R. Grever
Kenneth K. Chan
John C. Byrd
Show All
Source
Cite
Save
Citations (128)
1